Meta AnalysisID 671
使用雌二醇、孕激素或避孕药作为促性腺激素释放激素拮抗剂方案预处理的效果
CRD42020187219
What is the effect of using estradiol, progestogen, or combined oral contraceptive pill as pretreatment for IVF GnRH antagonist cycles?
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 671
- Evidence Id
- 9229
- Core Evidence Id
- 9229
- Source Meta Analysis Id
- 650
- Herb2 Meta Analysis Id
- HBMA000650
- Crd Id
- CRD42020187219
- Title
- The effect of using of estradiol, progestogen, or contraceptive pill as pretreatment for GnRH antagonist cycles
- Review Question
- What is the effect of using estradiol, progestogen, or combined oral contraceptive pill as pretreatment for IVF GnRH antagonist cycles?
- Study Type Included
- We include randomised controlled trials and observational studies.
- Condition Being Studied
- We would like to the study the effect of using of estradiol, progestogen, or contraceptive pill as pretreatment for GnRH antagonist cycles in relationship to live birth rate, miscarriage rate, stillbirth rate, cycle scheduling, OHSS rate, number of oocytes retrieved and ovarian cyst formation.
- Participant
- Women treated with estradiol, progestogen, or contraceptive pill as pretreatment for specifically GnRH antagonist IVF cycles
- Animal
- Human Disease Modelled
- Intervention
- The intervention is the use of estradiol, progestogen, or combined oral contractive pill as pretreatment prior to starting IVF antagonist cycle.
- Comparator Control
- The control is women not using pretreatment or using alternative pretreatment prior to starting IVF antagonist cycle.
- Main Outcome
- Pregnancy outcomes - live birth >24 weeks gestation Measures of effect Relative risks for randomised controlled trials Odds ratios for observational studies
- Outcome Measure
- Additional Outcome
- Pregnancy loss - miscarriage (pregnancy loss <24 weeks gestation), stillbirth (pregnancy loss >24 weeks gestation) Effective cycle scheduling OHSS rate Number of oocytes retrieved Ovarian cyst formation Measures of effect Relative risks for randomised controlled trials Odds ratios for observational studies
- Study Method
- Meta-analysis, Systematic review
- Keyword
- Contraceptive Agents; Contraceptive Devices; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Progestins
- Contact
- Jane Ding [email protected]
- Organisational Affiliation
- The Centre for Reproductive Medicine, St Bartholomew’s Hospital
- Funding Source
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- England
- Review Stage
- Review Ongoing
- First Submission Date
- 2020-07-12
- Registration Date
- 2020-10-13
- Anticipated Start Date
- 2020-05-19
- Anticipated Completion Date
- 2021-05-01
- Title Cn
- 使用雌二醇、孕激素或避孕药作为促性腺激素释放激素拮抗剂方案预处理的效果
- Title En
- The effect of using of estradiol, progestogen, or contraceptive pill as pretreatment for GnRH antagonist cycles
- Bilingual Status
- complete